The European Medicines Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the first time the vaccine has been authorised for people under the age of 18.
The European Medicines Agency approves the usage of the Moderna’s COVID-19 vaccine for children aged 12 to 17, becoming the first time the vaccine has been authorised for people under 18.
The European Medicines Agency approves the usage of the Moderna COVID-19 vaccine for children betweentheagesof12 and 17, becoming the first time the vaccine has been authorised for people undertheageof 18.